Blog
RSS FeedPosted by Michael Wonder on 17 Jul 2019
Breast cancer patients to have further NICE approved drug combination option on Cancer Drugs Fund
17 July 2019 - Another potentially life-extending drug combination for some people with advanced breast cancer will now be available on ...
Posted by Michael Wonder on 09 Jul 2019
Pharmacists v doctors: fiery prescription debate rages in WA
9 July 2019 - A proposal to allow pharmacists to issue repeat prescriptions should be backed as consumers will save ...
Posted by Michael Wonder on 09 Jul 2019
Pharma giant using loophole to falsely promote opioid pain relief product across Australia
10 July 2019 - Debbie Thompson is a grandmother of five who likes to crochet in her spare time. The ...
Posted by Michael Wonder on 09 Jul 2019
PHARMAC has spent tens of millions on OxyContin, blamed for America's opioid crisis
10 July 2019 - PHARMAC has spent tens of millions of dollars funding a painkiller at the centre of the ...
Posted by Michael Wonder on 09 Jul 2019
Institute for Clinical and Economic Review lists potential topics for assessments in 2020
9 July 2019 - The Institute for Clinical and Economic Review has released its preliminary list of potential assessment topics ...
Posted by Michael Wonder on 09 Jul 2019
UK launches subscription style payment pilot to incentivise pharma antibiotics R&D
9 July 2019 - The UK is to try out a subscription-style payment model aimed at incentivising pharma and biotech ...
Posted by Michael Wonder on 09 Jul 2019
NICE Onpattro approval puts Alnylam back in hATTR running
9 July 2019 - NICE has recommended the use of Alynylam’s Onpattro (patisiran), after issuing a preliminary ‘no’, back in ...
Posted by Michael Wonder on 09 Jul 2019
The fragility of phase 3 trials supporting FDA approved anti-cancer medicines: a retrospective analysis
8 July 2019 - The fragility index of trial results—ie, the minimum number of changes from non-events to events resulting in ...
Posted by Michael Wonder on 09 Jul 2019
Breast cancer specialists throw their weight behind long-running fight for increased Government drug funding
9 July 2019 - Several petitions, two marches on Parliament and countless emotive pleas have been fruitless in a long-running ...
Posted by Michael Wonder on 09 Jul 2019
FDA to speed review of generic versions of opioid overdose antidote
8 July 2019 - The US FDA on Monday said it would prioritise and expedite the review of generic versions ...
Posted by Michael Wonder on 09 Jul 2019
Trump rule requiring drug prices in TV ads blocked
8 July 2019 - Federal judge sides with companies, saying regulation would violate free speech. ...
Posted by Michael Wonder on 08 Jul 2019
New treatment approved for patients with breast cancer in Scotland
8 July 2019 - A new drug for patients with advanced breast cancer has been approved for use by the ...
Posted by Michael Wonder on 08 Jul 2019
Doctors slow to adopt tech tools that might save patients money on drugs
5 July 2019 - When Mary Kay Gilbert saw her doctor in May for a skin infection on her leg, ...
Posted by Michael Wonder on 08 Jul 2019
Priority review granted to BeiGene’s supplemental new drug application in China for tislelizumab in urothelial carcinoma
7 July 2019 - BeiGene today announced that the China National Medical Products Administration has granted priority review status to the ...
Posted by Michael Wonder on 08 Jul 2019
Report calls for European funding reform for gene therapies
8 July 2019 - New payment models, dedicated investment, and better health technology assessment are among a raft of changes ...
Posted by Michael Wonder on 08 Jul 2019
Speaker Pelosi, seize the moment to make history on drug pricing
8 July 2019 - House Speaker Nancy Pelosi has spent her entire life immersed in the Democratic Party, so she ...